Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients (Q61735285)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1

Mario Cruciani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Giovanni Serpelloni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Andrea Lanza

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Maurizio Gomma

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Stefano Nardi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Claudia Rimondo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Francesco Bricolo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sandro Consolaro

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

MariaTeresa Trevisan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Oliviero Bosco

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

English

0 references

publication date

5 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

17-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Hepatitis A and B Vaccination Practices for Ambulatory Patients Infected with HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Preventing hepatitis A and hepatitis B virus infections among men who have sex with men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Impaired response to hepatitis B vaccine in HIV infected children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.040

10.1016/J.VACCINE.2008.10.040

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18984022%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference